| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.085 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |